Falette N - Search Results

1

BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.

el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. el-Ghissassi F, et al. Among authors: falette n. Oncogene. 2002 Oct 3;21(44):6772-78. doi: 10.1038/sj.onc.1205888. Oncogene. 2002. PMID: 12360398

2

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.

Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A. Duriez C, et al. Among authors: falette n. Gene. 2002 Jan 9;282(1-2):207-14. doi: 10.1016/s0378-1119(01)00825-3. Gene. 2002. PMID: 11814693

3

BTG2, its family and its tutor.

Duriez C, Moyret-Lalle C, Falette N, El-Ghissassi F, Puisieux A. Duriez C, et al. Among authors: falette n. Bull Cancer. 2004 Jul-Aug;91(7-8):E242-53. Bull Cancer. 2004. PMID: 15381462 Free article. Review.

4

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.

Guillot C, Falette N, Paperin MP, Courtois S, Gentil-Perret A, Treilleux I, Ozturk M, Puisieux A. Guillot C, et al. Among authors: falette n. Oncogene. 1997 Jan 9;14(1):45-52. doi: 10.1038/sj.onc.1200803. Oncogene. 1997. PMID: 9010231

5

Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.

Duriez C, Falette N, Cortes U, Moyret-Lalle C, Puisieux A. Duriez C, et al. Among authors: falette n. Oncogene. 2000 May 11;19(20):2461-4. doi: 10.1038/sj.onc.1203580. Oncogene. 2000. PMID: 10828889

6

Chfr inactivation is not associated to chromosomal instability in colon cancers.

Bertholon J, Wang Q, Falette N, Verny C, Auclair J, Chassot C, Navarro C, Saurin JC, Puisieux A. Bertholon J, et al. Among authors: falette n. Oncogene. 2003 Dec 4;22(55):8956-60. doi: 10.1038/sj.onc.1207078. Oncogene. 2003. PMID: 14654793

7

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.

Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, Morel AP, Hainaut P, Magaud JP, Puisieux A. Cortes U, et al. Among authors: falette n. Mol Carcinog. 2000 Feb;27(2):57-64. Mol Carcinog. 2000. PMID: 10657898

8

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: falette n. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

9

Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.

Galmarini CM, Voorzanger N, Falette N, Jordheim L, Cros E, Puisieux A, Dumontet C. Galmarini CM, et al. Among authors: falette n. Biochem Pharmacol. 2003 Jan 1;65(1):121-9. doi: 10.1016/s0006-2952(02)01448-x. Biochem Pharmacol. 2003. PMID: 12473386

10

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.

Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. Rouault JP, et al. Among authors: falette n. Nat Genet. 1996 Dec;14(4):482-6. doi: 10.1038/ng1296-482. Nat Genet. 1996. PMID: 8944033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters